Cancer Treatment Reviews
Volume 36, Issue 5 , Pages 410-415, August 2010

Lapatinib and HER2 status: Results of a meta-analysis of randomized phase III trials in metastatic breast cancer

Division of Medical Oncology, University of Toronto and Princess Margaret Hospital, Toronto, Canada

Received 14 October 2009; received in revised form 16 December 2009; accepted 26 December 2009. published online 25 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(10)00002-2

doi:10.1016/j.ctrv.2009.12.012

Cancer Treatment Reviews
Volume 36, Issue 5 , Pages 410-415, August 2010

Article Tools

* Image Usage & Resolution